Immutep Limited (IMMP)
NASDAQ: IMMP · Real-Time Price · USD
0.5730
+0.0021 (0.37%)
At close: Apr 24, 2026, 4:00 PM EDT
0.5800
+0.0070 (1.22%)
After-hours: Apr 24, 2026, 7:59 PM EDT

Immutep Revenue

Immutep had revenue of 4.10M AUD in the half year ending December 31, 2025, with 4,506.79% growth. This brings the company's revenue in the last twelve months to 4.13M, up 7,650.57% year-over-year. In the fiscal year ending June 30, 2025, Immutep had annual revenue of 59.71K, down -49.86%.

Revenue (ttm)
4.13M AUD
Revenue Growth
+7,650.57%
P/S Ratio
13.94
Revenue / Employee
133,292 AUD
Employees
31
Market Cap
73.66M USD

Revenue Chart

* This company reports financials in AUD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 202559.71K-59.38K-49.86%
Jun 30, 2024119.09K-72.63K-37.88%
Jun 30, 2023191.72K-62.67K-24.63%
Jun 30, 2022254.39K-58.45K-18.68%
Jun 30, 2021312.84K-7.45M-95.97%
Jun 30, 20207.77M6.47M499.78%
Jun 30, 20191.29M-2.34M-64.42%
Jun 30, 20183.64M2.84M354.63%
Jun 30, 2017800.46K625.41K357.27%
Jun 30, 2016175.05K--
Jun 30, 2015---
Jun 30, 2014---
Jun 30, 2013---
Jun 30, 2012---
Jun 30, 2011---
Jun 30, 2010---
Jun 30, 2009---
Jun 30, 2008---
Jun 30, 2007---
Jun 30, 2006---
Jun 30, 2005---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Fortress Biotech63.26M
ImmuCell27.64M
Pelthos Therapeutics16.80M
TScan Therapeutics10.33M
aTyr Pharma190.00K
Revenue Rankings